Ingredion (NYSE:INGR – Get Free Report) released its quarterly earnings results on Tuesday. The company reported $3.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.58 by $0.47, Briefing.com reports. The company had revenue of $1.87 billion during the quarter, compared to the consensus estimate of $1.94 billion. Ingredion had a net margin of 8.47% and a return on equity of 17.18%. Ingredion’s revenue was down 8.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.33 earnings per share. Ingredion updated its FY 2024 guidance to 10.350-10.650 EPS and its FY24 guidance to $10.35-$10.65 EPS.
Ingredion Price Performance
INGR traded up $0.68 during trading on Thursday, hitting $151.20. 33,338 shares of the company traded hands, compared to its average volume of 377,077. The company has a market cap of $9.84 billion, a PE ratio of 15.39, a P/E/G ratio of 1.21 and a beta of 0.73. The stock’s 50-day simple moving average is $135.54 and its two-hundred day simple moving average is $124.93. Ingredion has a 1 year low of $100.01 and a 1 year high of $155.44. The company has a current ratio of 2.52, a quick ratio of 1.51 and a debt-to-equity ratio of 0.47.
Ingredion Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, October 22nd. Investors of record on Tuesday, October 1st were paid a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a yield of 2.12%. This is a boost from Ingredion’s previous quarterly dividend of $0.78. The ex-dividend date of this dividend was Tuesday, October 1st. Ingredion’s dividend payout ratio (DPR) is presently 32.72%.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Report on Ingredion
Insider Activity at Ingredion
In other Ingredion news, CEO James P. Zallie sold 22,550 shares of Ingredion stock in a transaction on Friday, August 30th. The shares were sold at an average price of $134.14, for a total value of $3,024,857.00. Following the completion of the transaction, the chief executive officer now directly owns 52,530 shares of the company’s stock, valued at $7,046,374.20. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. In other Ingredion news, CEO James P. Zallie sold 1,300 shares of Ingredion stock in a transaction on Wednesday, August 28th. The shares were sold at an average price of $134.03, for a total value of $174,239.00. Following the completion of the transaction, the chief executive officer now directly owns 52,530 shares of the company’s stock, valued at $7,040,595.90. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO James P. Zallie sold 22,550 shares of Ingredion stock in a transaction on Friday, August 30th. The stock was sold at an average price of $134.14, for a total transaction of $3,024,857.00. Following the completion of the transaction, the chief executive officer now directly owns 52,530 shares of the company’s stock, valued at $7,046,374.20. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 25,356 shares of company stock valued at $3,400,709. Corporate insiders own 1.80% of the company’s stock.
Ingredion Company Profile
Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.
Featured Articles
- Five stocks we like better than Ingredion
- Dividend Payout Ratio Calculator
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Find and Profitably Trade Stocks at 52-Week Lows
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Atlassian Is Up +60% in Three Months—What’s Causing the Rally?
Receive News & Ratings for Ingredion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingredion and related companies with MarketBeat.com's FREE daily email newsletter.